Fox Run Management L.L.C. Sells 63,618 Shares of Aspen Aerogels, Inc. $ASPN

Key Points

• Fox Run Management L.L.C. reduced its stake in Aspen Aerogels, selling 63,618 shares, resulting in a 72.6% decrease in holdings, with remaining shares valued at $153,000.
• Major hedge funds significantly increased their positions in Aspen Aerogels during the last quarter, with Millennium Management LLC expanding its holdings by 4,757.8% to own over 1.6 million shares valued at around $19 million.
• Aspen Aerogels reported a loss of ($0.04) EPS for the recent quarter, surpassing the expected loss, and set a FY 2025 guidance of expected losses between -$3.860 to -$3.730 EPS.

Fox Run Management L.L.C. reduced its stake in Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) by 72.6% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 23,955 shares of the construction company's stock after selling 63,618 shares during the period. Fox Run Management L.L.C.'s holdings in Aspen Aerogels were worth $153,000 as of its most recent SEC filing.

Other institutional investors have also recently modified their holdings of the company. GAMMA Investing LLC grew its stake in shares of Aspen Aerogels by 1,998.7% in the first quarter. GAMMA Investing LLC now owns 3,316 shares of the construction company's stock worth $210,000 after acquiring an additional 3,158 shares during the last quarter. Banque Cantonale Vaudoise purchased a new stake in shares of Aspen Aerogels in the first quarter worth $45,000. Exchange Traded Concepts LLC grew its stake in shares of Aspen Aerogels by 460.4% in the first quarter. Exchange Traded Concepts LLC now owns 7,436 shares of the construction company's stock worth $48,000 after acquiring an additional 6,109 shares during the last quarter. Sandia Investment Management LP bought a new position in shares of Aspen Aerogels during the fourth quarter valued at $89,000. Finally, CWM LLC lifted its holdings in shares of Aspen Aerogels by 2,137.9% during the first quarter. CWM LLC now owns 8,325 shares of the construction company's stock valued at $53,000 after purchasing an additional 7,953 shares in the last quarter. 97.64% of the stock is owned by hedge funds and other institutional investors.

Aspen Aerogels Stock Performance

ASPN stock traded down $0.09 during trading on Wednesday, reaching $7.04. The stock had a trading volume of 1,086,084 shares, compared to its average volume of 2,655,628. Aspen Aerogels, Inc. has a 52 week low of $4.16 and a 52 week high of $30.24. The stock's 50 day moving average is $6.97 and its two-hundred day moving average is $6.70. The company has a current ratio of 3.98, a quick ratio of 3.31 and a debt-to-equity ratio of 0.34. The firm has a market cap of $579.40 million, a PE ratio of -1.85 and a beta of 2.73.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last posted its earnings results on Thursday, August 7th. The construction company reported ($0.04) earnings per share for the quarter, beating analysts' consensus estimates of ($0.12) by $0.08. Aspen Aerogels had a positive return on equity of 2.92% and a negative net margin of 78.53%.The company had revenue of $78.02 million for the quarter, compared to the consensus estimate of $72.53 million. During the same quarter in the prior year, the company earned $0.21 earnings per share. Aspen Aerogels's revenue was down 33.8% on a year-over-year basis. Aspen Aerogels has set its FY 2025 guidance at -3.860--3.730 EPS. As a group, equities analysts anticipate that Aspen Aerogels, Inc. will post 0.17 earnings per share for the current year.

Insider Activity at Aspen Aerogels

In other news, CAO Santhosh P. Daniel sold 4,410 shares of the firm's stock in a transaction dated Tuesday, August 12th. The stock was sold at an average price of $7.31, for a total value of $32,237.10. Following the transaction, the chief accounting officer owned 19,879 shares of the company's stock, valued at $145,315.49. This trade represents a 18.16% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 4.30% of the stock is owned by company insiders.

Analyst Ratings Changes

A number of research analysts have recently issued reports on ASPN shares. Canaccord Genuity Group lowered their price target on Aspen Aerogels from $11.00 to $10.00 and set a "buy" rating on the stock in a report on Friday, August 8th. Oppenheimer downgraded Aspen Aerogels from an "outperform" rating to a "market perform" rating in a report on Thursday, May 8th. Finally, Barclays downgraded Aspen Aerogels from an "equal weight" rating to an "underweight" rating and upped their price target for the company from $7.00 to $16.00 in a report on Monday, August 11th. One analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Aspen Aerogels has an average rating of "Moderate Buy" and an average price target of $19.50.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.